CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 63 enrolled
Drug / intervention
D-SQUAME Skin Sampling Discsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02511782
NCT02511782N/ACompleted

Use of a Transdermal Patch to Noninvasively Monitor Inflammatory Biomarkers of Acute and Chronic Skin GVHD

Children's Hospital Medical Center, Cincinnati·interventional·Posted Jul 30, 2015·Updated May 4, 2017

In Brief

A clinical study evaluating D-SQUAME Skin Sampling Discs for Graft Versus Host Disease. Completed, enrolled 63 participants across 1 site.

Detailed Summary

The aim of this study is to measure local inflammatory responses in patients undergoing an allogeneic stem cell transplant and attempt to define any set of biomarkers that are significantly altered in acute or chronic skin graft versus host disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 30, 2015
Enrollment StartFeb 1, 2012
Primary CompletionJun 1, 2014
Study CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 10.9 years ago

Interventions

D-SQUAME Skin Sampling Discsdevice

A D-SQUAME Skin Sampling Disc is a noninvasive patch that collects skin cell samples when affixed to the superficial stratum corneum (top layer of skin). The patch is applied with gentle pressure to the desired quadrant of the forearm and removed 2 minutes after application.